Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Large-scale testing (Phase 3)WithdrawnNCT01345084
What this trial is testing

Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab

Who this might be right for
CarcinomaHead and Neck Cancer
Eurofarma Laboratorios S.A.
Testing effectiveness (Phase 2)UnknownNCT05594914
What this trial is testing

AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of University of South China 47
Testing effectiveness (Phase 2)UnknownNCT03817658
What this trial is testing

A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 725
Early research (Phase 1)Active Not RecruitingNCT04007744
What this trial is testing

Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+19 more
Mayo Clinic 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04550260
What this trial is testing

Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
AstraZeneca 640
Testing effectiveness (Phase 2)Study completedNCT00623558
What this trial is testing

Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Neoplasm
Seoul National University Hospital 92
Testing effectiveness (Phase 2)WithdrawnNCT03114280
What this trial is testing

Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Centre Antoine Lacassagne
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05945823
What this trial is testing

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Cancer+2 more
Taiho Oncology, Inc. 53
Large-scale testing (Phase 3)Study completedNCT04187352
What this trial is testing

CS1001 in Subjects With Esophageal Squamous Cell Carcinoma

Who this might be right for
Unresectable Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
CStone Pharmaceuticals 540
Testing effectiveness (Phase 2)Study completedNCT03624231
What this trial is testing

Feasibility & Efficacy of Durvalumab+Tremelimumab+RT and Durvalumab+RT in Non-resect. Locally Advanced HPVnegativ HNSCC

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Ulrich Keilholz 18
Not applicableEnded earlyNCT01303237
What this trial is testing

A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Unresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckLA SCCHN
Merck KGaA, Darmstadt, Germany 88
Large-scale testing (Phase 3)UnknownNCT00999700
What this trial is testing

Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Gruppo Oncologico del Nord-Ovest 282
Testing effectiveness (Phase 2)Looking for participantsNCT07519486
What this trial is testing

Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaLocally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Sichuan University 118
Testing effectiveness (Phase 2)Looking for participantsNCT06173986
What this trial is testing

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaUnresectable Locally Advanced Esophageal Cancer
Shanghai Chest Hospital 50
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Testing effectiveness (Phase 2)Looking for participantsNCT06988956
What this trial is testing

Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University 95
Testing effectiveness (Phase 2)Ended earlyNCT00109850
What this trial is testing

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 22
Testing effectiveness (Phase 2)Looking for participantsNCT06410651
What this trial is testing

Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerNimotuzumabChemoradiotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 53
Load More Results